NASDAQ · BNR

Burning Rock Biotech Limited news

$18.94+7.43%

Close Sep 29, 2026 · split-adjusted

Articles · 30 days0English, de-duplicated

Positive0

Neutral0

Negative0

About Burning Rock Biotech Limited

No recent articles focused on Burning Rock Biotech Limited.

Also mentions BNR

Articles that tag BNR but are mainly about other companies.

Cancer screening company Faces Tough IPO Test As Market Cools

BenzingaApr 16, 10:40 AM ET▼ Negative

Received Nasdaq delisting warning after share price fell below $1, forced to cut 18% of workforce in 2024, and required a 1-for-10 reverse stock split to maintain listing eligibility.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology